Loading ......
What an exosome carries is, in a sense, its reason for existing. The vesicle packages a selection of proteins, RNA species, lipids, and small metabolites drawn from its parent cell and delivers that molecular cargo to neighboring or distant cells, where it can alter behavior. This transfer of functional molecules is the mechanism by which exosomes exert many of their biological effects, and it is also what makes them useful as both disease markers and therapeutic vehicles.
Exosomal cargo is remarkably diverse, encompassing proteins involved in signaling and metabolism — such as heat-shock proteins like HSP70 and HSP90, cytoskeletal proteins like actin and tubulin, the ESCRT-associated proteins TSG101 and ALIX, and metabolic enzymes such as GAPDH — many classes of RNA including messenger RNA and microRNA, lipids that reflect membrane origin, and a variety of small metabolites. Because the cargo is derived from the parent cell, its composition tends to reflect that cell's identity, activation state, and health. A vesicle released by an immune cell, for example, carries a different protein and RNA profile than one released by a cell of neural or endothelial origin. This fidelity is what makes exosomes informative: they act as a concentrated molecular photograph of the cell that produced them, transported out into body fluids where it can be sampled. The diversity of cargo also means that a single vesicle population can influence recipient cells through multiple concurrent mechanisms, since proteins and nucleic acids can each elicit distinct responses depending on the context of delivery.
Figure 1. Exosomes are mainly composed of lipids, proteins and nucleic acids. (Source: Qiu M, et al. 2024)
A key insight from exosome biology is that cargo is not packaged at random. Specific RNA and protein species are enriched in vesicles relative to the parent cell, indicating the existence of sorting mechanisms that select what enters. For RNA, particular sequences and structures are recognized by RNA-binding proteins that chaperone them into budding vesicles; one well-characterized example is a nuclear protein that, when modified by a small-protein tag, binds specific motifs in certain microRNAs and directs their incorporation. Broader sorting machinery, including the ESCRT pathway components TSG101 and ALIX and the tetraspanin-binding protein syntenin-1, as well as several ESCRT-independent routes, contributes to the packaging of both proteins and RNAs. The RNA-binding protein hnRNPA2B1, when modified by a small-protein tag, is one of the factors that recognizes specific motifs in certain microRNAs and directs their incorporation into vesicles, and surface tetraspanins such as CD9, CD63, and CD81 are typically co-enriched as identifying markers of a preparation. These selective processes explain why the vesicle cargo profile is a refined signal rather than a random fragment of cellular contents, and they also suggest that the cargo composition can be deliberately influenced, a principle of interest for both understanding physiology and designing vesicles with defined contents.
Figure 2. Overview of RNA and Protein sorting to EVs. (Source: Wang BZ, et al. 2022)
Once released, exosomes deliver their cargo to recipient cells through fusion or internalization, and research has shown that the transferred material can be functionally active in the new environment. Messenger RNA delivered by vesicles has been shown to be translated into protein in recipient cells, and microRNAs such as members of the let-7 and miR-21 families delivered in the same way can modulate gene expression by repressing target transcripts. Proteins carried in the vesicle can engage receptors or enter signaling pathways directly; in some tumor contexts, receptor proteins such as EGFR have been found among vesicular cargo, where they can support signaling in recipient cells. The consequence is that exosomes can coordinate the behavior of distant cells, spreading a molecular program from one cell type to another. This capacity has been observed in both physiological regulation and pathology: in some disease contexts, vesicles released by malignant cells have been found to transport RNA and proteins that support growth and that serve as detectable markers of the underlying process. The general principle is that exosome-mediated transfer is a form of intercellular communication in which the message is not a single soluble factor but a coordinated set of macromolecules.
The dual nature of exosomal cargo — informative and active — underlies its value in two directions. As a signature, the cargo provides a readout of the parent tissue that can be profiled to detect disease or monitor its evolution, which is the basis of exosome-based diagnostics. As an effector, the same cargo is the means by which exosomes influence recipient cells, which is the basis of their therapeutic potential. Compendia that catalog the RNA, protein, lipid, and metabolite content reported across many vesicle studies — including commonly profiled microRNAs such as miR-21, miR-100, and miR-375 and proteins such as HSP70, TSG101, and CD63 — provide a resource for interpreting what a given preparation contains and for designing new experiments, while also highlighting the breadth of molecules that can travel by this route. The challenge is that cargo is heterogeneous and often present at low abundance, so robust detection requires sensitive methods and careful interpretation. Even so, the idea that cells routinely exchange organized packets of their molecular contents has reshaped how communication between tissues is understood.
Although proteins and RNA dominate discussion of exosomal cargo, lipids and small metabolites form an equally instructive portion of the vesicular contents. The lipidome of an exosome reflects both the membrane from which it was formed and the metabolic state of the parent cell, and specific lipid species have been shown to differ between physiological and pathological vesicle populations. Metabolites carried within the lumen can report on the energetic and biosynthetic status of the source cell, adding a dimension of information that nucleic-acid and protein profiling alone may miss. Because lipids and metabolites are small and chemically diverse, their analysis requires complementary methods rather than the sequencing and antibody tools used for RNA and protein, yet they are valuable precisely because they integrate cellular physiology in real time. Including lipid and metabolite readouts alongside the better-characterized cargo classes gives a more complete molecular picture and may surface disease associations that would otherwise remain hidden.
Demonstrating that cargo transfer occurs, and that it changes recipient-cell behavior, requires methods that can follow vesicles and their contents across the communication event. Labeling strategies that mark the vesicle membrane or its lumen allow tracking of where a vesicle travels and whether it is taken up, while reporters that respond only after delivery confirm that the cargo has entered the recipient's active compartments. Coupling these readouts with measurements of downstream gene or protein changes links the physical transfer to a functional outcome. Such integrated approaches are important because not every vesicle that binds a cell will deliver its cargo, and not every delivered molecule will exert a measurable effect; distinguishing productive transfer from mere association is what turns an observation of co-localization into evidence of communication. As these methods mature, they sharpen both the biological picture and the criteria used to judge vesicle-based products.
References
| Target | Cat. No. | Product Name | Expression System | Tag/Conjugate | Application | |
| Exosome | DAGA-987 | Purified exosomes from plasma of healthy donors | Plasma of healthy donors | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry |
| DAGA-988 | Purified exosomes from urine of healthy donors | Urine of healthy donors | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-989 | Purified exosomes from COLO1 cell culture supernatant | Human Colon Carcinoma cell line COLO1 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-990 | Purified exosomes from MM1 cell culture supernatant | Human Melanoma cell line MM1 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-991 | Purified exosomes from BLCL cell culture supernatant | BLCL21 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-992 | Purified exosomes from HCT116 cell culture supernatant | Human Colon Carcinoma cell line HCT116 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-993 | Purified exosomes from U87 MG cell culture supernatant | Human Glioblastoma-Astrocytoma cell line U87 MG | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-994 | Purified exosomes from SK-N-SH cell culture supernatant | Human Neuroblastoma cell line SK-N-SH | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-995 | Purified exosomes from PC3 cell culture supernatant | Human Prostate adenocarcinoma grade IV cell line PC3 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-996 | Purified exosomes from BPH-1 cell culture supernatant | Human being prostatic hyperplasia cell line BPH-1 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-997 | Purified exosomes from DAUDI cell culture supernatant | Human Burkitt Lymphoma cell line DAUDI | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-998 | Purified exosomes from A549 cell culture supernatant | Lung carcinoma cell line A549 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-999 | Purified exosomes from K562 cell culture supernatant | Pleural effusion, leukemia chronic myelogenous cell line K562 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-1000 | Purified exosomes from B16F10 mouse cell culture supernatant | Mouse melanoma cell line B16F10 | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-1001 | Purified exosomes from serum of healthy donors | Serum of healthy donors | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-1002 | Purified exosomes from saliva of healthy donors | Saliva of healthy donors | Unconjugated | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAGA-1003 | Fluorescent labeled Exosome Standards | N/A | FITC | Fluorescence microscopy, Flow cytometry, EM | Inquiry | |
| DAG-WT3255 | Purified exosomes from HEK293 cell line | HEK293 cells | N/A | Calibration, Control, Flow cytometry, EM | Inquiry | |
| DAG-WT1158 | Purified exosomes from MSC | MSC from Adipose tissue | N/A | Calibration, Control, Flow cytometry, EM | Inquiry |
Loading ......